Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth D Friedman

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Pediatric Blood & Cancer|March 23, 2011
Therapeutic consequences for misdiagnosis of type 2N von Willebrand diseaseMadhu Gupta, David Lillicrap, Ann Marie Stain, et al.
Journal of Clinical Apheresis|March 3, 2009
Value of ADAMTS13 activity and inhibitor in the postmortem diagnosis of thrombotic thrombocytopenic purpuraDenis M Dwyre, Bryce Dursteler, Marcus Nashelsky, et al.
Transfusion|April 29, 2026
Concomitant acquired and inherited von Willebrand disease: A challenging bleeding disorderNikita J Sareen, Kenneth D Friedman, Mia J Sullivan, et al.
Transfusion|January 9, 2007
Comparison and stability of ADAMTS13 activity in therapeutic plasma productsErik A Scott, Kathleen E Puca, Bradley C Pietz, et al.
Pediatric Blood & Cancer|November 7, 2012
Use of purified fibrinogen concentrate for dysfibrinogenemia and importance of laboratory fibrinogen activity measurementEmily B Franzblau, Rowena C Punzalan, Kenneth D Friedman, et al.
Journal of Clinical Apheresis|July 11, 2009
Elevated procalcitonin and C-reactive protein as potential biomarkers of sepsis in a subpopulation of thrombotic microangiopathy patientsYasuko O Erickson, Noelle I Samia, Bruce Bedell, et al.
Seminars in Thrombosis and Hemostasis|November 22, 2011
Von Willebrand disease in the United States: a perspective from WisconsinVeronica H Flood, Joan Cox Gill, Kenneth D Friedman, et al.
Journal of Pediatric Hematology/Oncology|September 9, 2008
Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrowWilliam B Slayton, Milin Patel, Martha Sola-Visner, et al.
Blood|March 21, 2012
Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storagePaula M Jacobi, Joan Cox Gill, Veronica H Flood, et al.
Transfusion|September 24, 2017
Successful kidney transplantation in a patient with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome)Hasan Fattah, Dhiren Kumar, James N George, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Pediatric Blood & Cancer|March 23, 2011
Therapeutic consequences for misdiagnosis of type 2N von Willebrand diseaseMadhu Gupta, David Lillicrap, Ann Marie Stain, et al.
Journal of Clinical Apheresis|March 3, 2009
Value of ADAMTS13 activity and inhibitor in the postmortem diagnosis of thrombotic thrombocytopenic purpuraDenis M Dwyre, Bryce Dursteler, Marcus Nashelsky, et al.
Transfusion|April 29, 2026
Concomitant acquired and inherited von Willebrand disease: A challenging bleeding disorderNikita J Sareen, Kenneth D Friedman, Mia J Sullivan, et al.
Transfusion|January 9, 2007
Comparison and stability of ADAMTS13 activity in therapeutic plasma productsErik A Scott, Kathleen E Puca, Bradley C Pietz, et al.
Pediatric Blood & Cancer|November 7, 2012
Use of purified fibrinogen concentrate for dysfibrinogenemia and importance of laboratory fibrinogen activity measurementEmily B Franzblau, Rowena C Punzalan, Kenneth D Friedman, et al.
Journal of Clinical Apheresis|July 11, 2009
Elevated procalcitonin and C-reactive protein as potential biomarkers of sepsis in a subpopulation of thrombotic microangiopathy patientsYasuko O Erickson, Noelle I Samia, Bruce Bedell, et al.
Seminars in Thrombosis and Hemostasis|November 22, 2011
Von Willebrand disease in the United States: a perspective from WisconsinVeronica H Flood, Joan Cox Gill, Kenneth D Friedman, et al.
Journal of Pediatric Hematology/Oncology|September 9, 2008
Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrowWilliam B Slayton, Milin Patel, Martha Sola-Visner, et al.
Blood|March 21, 2012
Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storagePaula M Jacobi, Joan Cox Gill, Veronica H Flood, et al.
Transfusion|September 24, 2017
Successful kidney transplantation in a patient with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome)Hasan Fattah, Dhiren Kumar, James N George, et al.
Pageof 5